Is FUNDACIÓ Hospital Universitari Vall D'HEBRON—INSTITUT DE Recerca's patent grant rate increasing or decreasing?

FUNDACIÓ Hospital Universitari Vall D'HEBRON—INSTITUT DE Recerca's recent grant velocity is +14% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for FUNDACIÓ Hospital Universitari Vall D'HEBRON—INSTITUT DE Recerca's patents?

FUNDACIÓ Hospital Universitari Vall D'HEBRON—INSTITUT DE Recerca's patents average 15.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

FUNDACIÓ Hospital Universitari Vall D'HEBRON—INSTITUT DE Recerca

Q: Where does FUNDACIÓ Hospital Universitari Vall D'HEBRON—INSTITUT DE Recerca rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), FUNDACIÓ Hospital Universitari Vall D'HEBRON—INSTITUT DE Recerca ranks #17,683 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Q: How is the FUNDACIÓ Hospital Universitari Vall D'HEBRON—INSTITUT DE Recerca patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 16 granted patents across 11 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Fundació ranks #17,683 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 11 technology areas.

#17,683
of 49,997 US assignees by volume: 48th percentile
by Innovation Score (34.5/100): 15.4
avg claims per patent: +14%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17683 · Foreign Corporation #17,683 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #17,683/49,997
PHOTO-FINISH Farmobile
CPC-FOCUS A61P · 11 areas
INNOV-THIN 34.5/100
CLAIMS-RICH 15.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +14% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Farmobile LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Fundació’s 34.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (28%) Velocity 3.8 pts (11%) Breadth 11.7 pts (34%) Claim depth 9.2 pts (27%)

Qualcomm Incorporated · highest

85
FUNDACIÓ Hospital… · this assignee

35
3D Lighting… · lowest

7

What this shows Fundació's Innovation Score is 34.5/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Fundació?

Each dot is one of Fundació’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fundació’s own 15.4 claims/patent is ABOVE the 12.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Fundació vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Fundació's grants concentrate

FUNDACIÓ Hospital Universitari Vall D'HEBRON—INSTITUT DE Recerca is a focused PatentsView assignee: 11 CPC subclasses with 75% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2016. By volume, Fundació sits between Forcome (ZHEJIANG) Co., Ltd. and Flash Seats, LLC.

Fundació's three-year grant acceleration

FUNDACIÓ Hospital Universitari Vall D'HEBRON—INSTITUT DE Recerca shows 4 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Forcome (Zhejiang)

16
Foxtron Vehicle

16
Frankie4 IP 1 Pty

16
Fujibo Holdings

16
Farmobile

16
Field Controls

16
Fishing Chaos

16
Flash Seats

16
FundaciÓ Hospital… ◀

16

What this shows FUNDACIÓ holds 16 patents at rank #17,667, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near FUNDACIÓ

By rank, the assignees closest to #17,667 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in FUNDACIÓ's primary technology class.

Fundació's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 48th percentile higher than 48% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

FUNDACIÓ Hospital Universitari Vall D'HEBRON—INSTITUT DE Recerca patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	6.3%
2017	3	18.8%
2019	3	18.8%
2020	2	12.5%
2021	2	12.5%
2022	1	6.3%
2024	3	18.8%
2025partial year	1	6.3%

Which technologies does FUNDACIÓ Hospital Universitari Vall D'HEBRON—INSTITUT DE Recerca patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C07K - Peptides 3

C12Y - Enzymes 1

Y10T - Technical Subjects Covered BY Former US Classification 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

A61B - DIAGNOSIS; SURGERY; Identification 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

C07D - Heterocyclic Compounds 1

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

FUNDACIÓ Hospital Universitari Vall D'HEBRON—INSTITUT DE Recerca's patent record in context - here's where to go next.

FUNDACIÓ Hospital Universitari Vall D'HEBRON—INSTITUT DE Recerca's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 75% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #17,683 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare FUNDACIÓ Hospital Universitari Vall D'HEBRON—INSTITUT DE Recerca against Forcome (ZHEJIANG) Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.